Home > Category > Inhibitory Antibodies > Antibodies > Bispecific monoclonal antibody > Anti-Human CD3ExBCMA (Elranatamab;PF-06863135)

埃纳妥单抗

ChemLeader

Catalog No：CLA1688 CAS No.：2408850-14-4 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Anti-Human CD3ExBCMA (Elranatamab;PF-06863135)
CAS	2408850-14-4
Storage condition	-20°C for 3 years \| In solvent: -80°C for 1 year

Product details

Elranatamab is a novel BCMA/CD3 bispecific antibody, showing promising results in RRMM. It optimally bridges BCMA on myeloma cells with CD3 on T-cells, enhancing T-cell mediated anti-myeloma activity.

Related literature

Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM.

https://doi.org/10.1038/s41408-024-01200-w

Sorry, no related items

History

CL1869

SNX 2112 | PF-04928473

908112-43-6 98+%

CL2868

Telbivudine | L-ThyMidine | LDT-600 | Epavudine | NV 02B

3424-98-4 98+%

CLA1688

Anti-Human CD3ExBCMA (Elranatamab;PF-06863135)

2408850-14-4

HL1804

Quinovic acid 3-O-rhamnoside

104055-76-7 95+%

CL1810A

Plerixafor | AMD3100 | JM3100

Lecanemab (Anti-Amyloid Beta)

HCTU; O-(6-Chlorobenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium Hexafluorophosphate/O-(6-Chloro-1-hydrocibenzotriazol-1-yl)- -1,1,3,3-tetramethyluroniumhexafluorophosphate

330645-87-9 99+% HPLC

HL1855

Thaxtomin C

140111-05-3 96+%